We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Certara Inc
7 own
5 watching
Current Price
$10.61
$-0.41
(-3.72%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
1,682.9M
52-Week High
19.87000
52-Week Low
9.41000
Average Volume
0.82M
Dividend Yield
--
P/E Ratio
--
Market Capitalization1,682.9M52-Week High19.8700052-Week Low9.41000Average Volume0.82MDividend Yield--P/E Ratio--What does the Certara Inc do?
We accelerate medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. Biosimulation is a powerful technology used to conduct virtual trials using virtual patients to predict how drugs behave in different individuals. Biopharmaceutical companies use our proprietary biosimulation software throughout drug discovery and development to inform critical decisions that not only save significant time and money but also advance drug safety and efficacy, improving millions of lives each year. --- Certara, Inc. was incorporated in Delaware on June 27, 2017. Our principal executive offices are located at 100 Overlook Center, Suite 101, Princeton, New Jersey 08540. Our telephone number is (609) 716-7900. Our website address is www.certara.com.
Read More
How much money does Certara Inc make?
News & Events about Certara Inc.
Zolmax
1 year ago
Certara, Inc. (NASDAQ:CERT Get Rating) insider Patrick F. Smith sold 19,104 shares of the companys stock in a transaction on Monday, June 5th. The shares were sold at an average price of $21.55, for a total value of $411,691.20. Following the completion of the sale, the insider now directly owns 59,...
TipRanks Financial Blog
1 year ago
Bank of America Securities analyst Michael Ryskin reiterated a Buy rating on Certara (CERT Research Report) yesterday and set a price target of $... Bank of America Securities analyst Michael Ryskin reiterated a Buy rating on Certara (CERT –...
Globe Newswire
1 year ago
New deep learning capabilities will provide data and insight to inform property prioritization, novel structure design and literature-based analyses.PRINCETON, N.J., March 09, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, is adding deep learning ...
Zolmax
2years ago
Shares of Certara, Inc. (NASDAQ:CERT Get Rating) have received an average recommendation of Moderate Buy from the eight analysts that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the ...
Globe Newswire
2years ago
Certara improves software capabilities by expanding into deep learning and data fabricPRINCETON, N.J., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT),today announced it hasacquiredVyasaAnalytics, LLC. Vyasaprovides scalable deep-learning software whichallowslife sciences ...
Frequently Asked Questions
Frequently Asked Questions
What is Certara Inc share price today?
Can Indians buy Certara Inc shares?
How can I buy Certara Inc shares from India?
Can Fractional shares of Certara Inc be purchased?
What are the documents required to start investing in Certara Inc stocks?
What is today’s traded volume of Certara Inc?
What is today’s market capitalisation of Certara Inc?
What is the 52-Week High and Low Range of Certara Inc?
What percentage is Certara Inc down from its 52-Week High?
What percentage is Certara Inc up from its 52-Week Low?
Current Price
$10.61
$-0.41
(-3.72%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.